Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antioxidant
    (1)
  • Apoptosis
    (1)
  • Calcium Channel
    (1)
  • Epigenetic Reader Domain
    (1)
  • PROTACs
    (1)
  • Parasite
    (1)
  • Phospholipase
    (1)
  • c-Met/HGFR
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

d-609

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
D609
T1504483373-60-8
D609 (Tricyclodecan-9-yl-Xanthogenate) has a wide range of biological activities including antioxidant, antiapoptotic, anticholinergic, antitumor, anti-inflammatory, antiviral, antiproliferative, and neuroprotective activities.D609 acts by inducing competitive inhibition of PC-specific phospholipase C (PC-PLC) and sphingomyelin synthase (SMS). D609 acts by causing competitive inhibition of PC-specific phospholipase C (PC-PLC) and sphingomyelin synthase (SMS).
  • $53
In Stock
Size
QTY
NITD-609 Enantiomer
T678801193314-24-7
NITD-609 Enantiomer is an enantiomer of NITD-609 which is a spironone drug with antimalarial activity.
  • $82
In Stock
Size
QTY
TargetMol | Inhibitor Sale
FHD-609
FHD609, FHD 609
T751352676211-64-4
FHD-609 is an effective BRD9 inhibitor and PROTAC degrader, targeting the non-classical BAF (ncBAF) subunit BRD9, thereby depleting the SS18-SSX fusion protein, and can be used for the study of synovial sarcoma (SS).
  • $66
In Stock
Size
QTY
Cipargamin
NITD609, KAE609
T163261193314-23-6In house
Cipargamin (NITD609) is an effective antimalarial compound. It has an IC50 of appr 1 nM against P. falciparum.
  • $32
In Stock
Size
QTY
Savolitinib
Volitinib, HMPL-504, AZD-6094
TQ02101313725-88-0
Savolitinib (Volitinib) (AZD-6094) is an effective, selective, and orally bioavailable c-Met inhibitor (IC50s: 5 nM/3 nM for c-Met/p-Met).
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
17R(18S)-EpETE
T36215725246-18-4
17R(18S)-EpETE is an oxylipin and a cytochrome P450 metabolite of eicosapentaenoic acid .1,217R(18S)-EpETE is an activator of large-conductance calcium-activated potassium (BKCa) channels, increasing the potassium current amplitude by 15-fold in isolated rat cerebral artery vascular smooth muscle cells (VSMCs) at +60 mV when used at a concentration of 50 nM.2It has negative chronotropic effects in isolated neonatal rat cardiomyocytes (NRCMs; EC50= ~1-2 nM) and prevents calcium-induced increases in the spontaneous beating of NRCMs.3,4 1.Schwarz, D., Kisselev, P., Ericksen, S.S., et al.Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: Highly steroselective formation of 17(R), 18(S)-epoxyeicosatetraenoic acidBiochem. Pharmacol.67(8)1445-1457(2004) 2.Lauterbach, B., Barbosa-Sicard, E., Wang, M.H., et al.Cytochrome P450-dependent eicosapentaenoic acid metabolites are novel BK channel activatorsHypertension39(2 Pt. 2)609-613(2002) 3.Falck, J.R., Wallukat, G., Puli, N., et al.17(R),18(S)-Epoxyeicosatetraenoic acid, a potent eicosapentaenoic acid (EPA) derived regulator of cardiomyocyte contraction: Structure-activity relationships and stable analoguesJ. Med. Chem.54(12)4109-4118(2011) 4.Arnold, C., Markovic, M., Blossey, K., et al.Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of omega-3 fatty acidsJ. Biol. Chem.285(43)32720-32733(2010)
  • $323
35 days
Size
QTY
EG01377 dihydrochloride
T72276
EG01377 dihydrochloride is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1) , with a K d of 1.32 μM, and IC 50 s of 609 nM for both NRP1-a1 and NRP1-b1 . EG01377 dihydrochloride has antiangiogenic, antimigratory, and antitumor effects .
  • $1,330
1-2 weeks
Size
QTY